Cedar Mountain Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
EFG
PI
DA
BPWM
PAS
YIH
Cedar Mountain Advisors's ONCY Position: Q2 2026 in Review
Cedar Mountain Advisors held its Oncolytics Biotech (ONCY) position steady in Q2 2026 at 5,651 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #664.
Cedar Mountain Advisors first reported a position in ONCY in Q4 2019 and has held it in 27 quarters since. The position peaked at $27K in Q4 2019. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.
- Cedar Mountain Advisors held 5,651 shares of Oncolytics Biotech worth $5.37K as of Q2 2026.
- Cedar Mountain Advisors left its Oncolytics Biotech share count unchanged in Q2 2026.
- Oncolytics Biotech made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #664 holding.
- Cedar Mountain Advisors first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 27 quarters since.
- Cedar Mountain Advisors's Oncolytics Biotech position peaked at $27K in Q4 2019.
- 24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.
Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.